InterMune (ITMN) Set to Announce Quarterly Earnings on Wednesday
InterMune (NASDAQ:ITMN) is scheduled to be releasing its earnings data on Wednesday, October 30th. Persons interested in registering for the company’s earnings conference call can do so using this link.
InterMune (NASDAQ:ITMN) traded up 0.22% on Tuesday, hitting $13.72. 85,943 shares of the company’s stock traded hands. InterMune has a 52-week low of $7.23 and a 52-week high of $16.00. The stock’s 50-day moving average is $14.83 and its 200-day moving average is $11.09. The company’s market cap is $1.124 billion.
Several analysts have recently commented on the stock. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of InterMune in a research note to investors on Wednesday, September 18th. They now have a $17.00 price target on the stock. Analysts at Goldman Sachs Group Inc. raised their price target on shares of InterMune from $11.00 to $12.00 in a research note to investors on Wednesday, September 18th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $16.75.
InterMune, Inc (NASDAQ:ITMN), is a biotechnology company focused on the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.